Serum Institute Seeks Emergency Use Approval Of Covovax In South Africa

Novavax and Serum Institute of India (SII) announced a regulatory submission to the South African Health Products Regulatory Agency for emergency use authorization (EUA) of Novavax' recombinant...

from NDTV News - World-news https://ift.tt/3zHDv9E